News and Opinions  –  2020

New ReAct Report: Treatment of newborn sepsis is threatened – effective antibiotics essential

Share the article

2020-11-16

Neonatal sepsis, a condition caused by the body’s response to infections, affects four million newborns globally every year. It makes up 15% of all neonatal deaths and the majority occur in low-income countries. Alarmingly, and further complicating an already lethal condition, up to 40% of neonatal sepsis cases are due to resistant pathogens. Today, on World Children's Day, ReAct releases a new report on newborns, sepsis and antibiotic resistance.

Over 400 responses from 74 countries

ReAct conducted a web-based survey between July 29th – October15th, 2020 aiming to understand the awareness, availability of guidelines, general practice and potential challenges physicians face around neonatal sepsis and antimicrobial resistance. Over 400 responses from 74 countries were received.

  • Overall, 60% of respondents are very or even extremely worried about antimicrobial resistance as a threat to the effective treatment of neonatal sepsis.
  • 79% of respondents have seen an increasing trend of multidrug resistant infections over the last five years, regardless of the region and income level of the health care facility where they work.
  • In some low-income countries, physicians report that over 50% of the newborns they treat develop sepsis and that over 75% of neonatal sepsis cases are due to resistant pathogens.

More news and opinion